Lad Latesh, Friedman Jonathan, Li Huying, Bhaskar B, Ortiz de Montellano Paul R, Poulos Thomas L
Department of Molecular Biology and Biochemistry, Program in Macromolecular Structure, University of California, Irvine, California 92697-3900, USA.
Biochemistry. 2004 Apr 6;43(13):3793-801. doi: 10.1021/bi035451l.
Heme oxygenase oxidatively cleaves heme to biliverdin, leading to the release of iron and CO through a process in which the heme participates both as a cofactor and as a substrate. Here we report the crystal structure of the product, iron-free biliverdin, in a complex with human HO-1 at 2.19 A. Structural comparisons of the human biliverdin-HO-1 structure with its heme complex and the recently published rat HO-1 structure in a complex with the biliverdin-iron chelate [Sugishima, M., Sakamoto, H., Higashimoto, Y., Noguchi, M., and Fukuyama, K. (2003) J. Biol. Chem. 278, 32352-32358] show two major differences. First, in the absence of an Fe-His bond and solvent structure in the active site, the distal and proximal helices relax and adopt an "open" conformation which most likely encourages biliverdin release. Second, iron-free biliverdin occupies a different position and orientation relative to heme and the biliverdin-iron complex. Biliverdin adopts a more linear conformation and moves from the heme site to an internal cavity. These structural results provide insight into the rate-limiting step in HO-1 catalysis, which is product, biliverdin, release.
血红素加氧酶将血红素氧化裂解为胆绿素,通过一个血红素既作为辅因子又作为底物参与的过程导致铁和一氧化碳的释放。在此我们报告了无铁胆绿素产物与人类HO-1复合物的晶体结构,分辨率为2.19埃。将人类胆绿素-HO-1结构与其血红素复合物以及最近发表的大鼠HO-1与胆绿素-铁螯合物复合物的结构进行比较 [杉岛,M.,坂本,H.,东本,Y.,野口,M.,和福山,K.(2003年)《生物化学杂志》278卷,32352 - 32358页],发现两个主要差异。首先,在活性位点不存在铁-组氨酸键和溶剂结构的情况下,远端和近端螺旋松弛并采用一种“开放”构象,这很可能促进胆绿素的释放。其次,无铁胆绿素相对于血红素和胆绿素-铁复合物占据不同的位置和取向。胆绿素采用更线性的构象,并从血红素位点移动到内部腔室。这些结构结果为HO-1催化中的限速步骤,即产物胆绿素的释放,提供了深入见解。